6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Originaltext

Diese Übersetzung bewerten

Mit deinem Feedback können wir Google Übersetzer weiter verbessern

Latest Press Releases

Time	Headline
5h ago	Delivery Hero confirms approach by Uber Technologies’ with respect to potential takeover offer
6h ago	Refers to Item 7 on the agenda: Report on the audit of the consolidated financial statements of Grupa Kęty SA
8h ago	The 4th BOCHK Science and Technology Innovation Prize Award Ceremony Concludes with Great Success
15h ago	Buffalo Potash Files Annual Information Form and New Technical Report
16h ago	Ionik Announces 30-Day Extension of Senior Debt Facility

About

119.46CHF+0.22 +0.18%

Closed • Updated at 19:32 GMT+00:00

Market Cap$277.17B

P/E Ratio21.28

Volume2.12M

Beta1.10

RSI58.43

Gross Margin74.60%

Health TechnologyPharmaceuticals: Major

Novartis Ag — investor relations, events, news, and company updates on 6ix.

Latest News

Novartis advances RLT innovation and reinforces leadership in prostate cancer, breast cancer and hematology with new data at ASCO and EHA

New PSMAddition data show 58% lower risk of PSA progression with Pluvicto® in metastatic hormone-sensitive prostate cancer

Novartis breaks ground on Denton, Texas radioligand therapy site; construction now underway across all new US facilities

Model N Appoints Thomas Gibbs to Board of Directors

Novartis receives Health Canada approval for Fabhalta® oral treatment for adults with C3G

Community Chat

Ask AI